Biomedical Engineering Reference
In-Depth Information
5. Gruen JR, Weissman SM (1997) Evolving views of the major histocompatibility complex.
Blood 90(11):4252-4265
6. Andric Z, Simonovic R (2003) The HLA system. In: Balint B (ed) Transfusion medicine.
CTCI, Belgrade, pp 145-167
7. Roopenian DC, Simpson E (eds) (2000) Minor histocompatibility antigens: from the labora-
tory to the clinic. Landis Bioscience, Georgetown
8. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB (2002) HLA-G polymorphisms
in couples with recurrent sponaneous abortions. Tissue Antigens 60:122-132
9. Charron D (2005) Immunogenomics of hematopoietic stem cell transplantation. Pathol Biol
(Paris) 53(3):171-173
10. Charron D, Suberbielle-Boissel C, Al-Daccak R (2009) Immunogenicity and allogenicity: a
challenge of stem cell therapy. J Cardiovasc Transl Res 2(1):130-138
11. Yen BL, Chang CJ, Liu KJ, Chen YC, Hu HI, Bai CH, Yen ML (2009) Brief report-human
embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive
effects toward natural killer cells as well as T lymphocytes. Stem Cells 27(2):451-456
12. Cecka JM (1997) The role of HLA in renal transplantation. Human Imunol 56:6-16
13. Moore SB (2001) Is HLA matching benefical in liver transplantation? Liver Transplant
7:774-776
14. Petersdorf EW (2004) HLA matching in allogeneic stem cell transplantation. Curr Opin
Hematol 11(6):386-391
15. Müller CR (2002) Computer applications in the search for unrelated stem cell donors. Transpl
Immunol 10:227-240
16. Koh LP (2004) Unrelated umbilical cord blood transplant in children and adults. Ann Acad
Med Singapore 33(5):559-569
17. Elsner HA, Blasczyk R (2004) Immunogenetics of HLA null alleles: implications for blood
stem cell transplant. Tissue Antigens 64(6):687-695
18. Balint B, Stamatovic D, Andric Z (2003) Stem and progenitor cell transplant. In: Balint B (ed)
Transfusion medicine. CTCI, Belgrade, pp 525-547
19. Balint B, Pavlovic M, Jevtic M, Hrvacevic R, Ostojic G, Ignjatovic L, Mijuskovic Z, Blagojevic
R, Trkuljic M (2007) Simple “closed-circuit” group-specific immunoadsorption system for
ABO-incompatible kidney transplants. Transf Apher Sci 36:225-233
20. Balint B, Pavlovic M, Todorovic M, Jevtic M, Ristanovic E, Lj I (2010) The use of simplified
ex vivo
immunoadsorption and “multi-manner” apheresis in ABO/H-mismatched kidney trans-
plant setting—phase II clinical study. Transf Apher Sci 43(2):141-148
21. Mazid MA, Kaplan M (1992) An improved affinity support and immunoadsorbent with a syn-
thetic blood group oligosaccharide and polymer coating for hemoperfusion. J Appl Biomater
3(1):9-15
22. Shishido S, Asanuma H, Tajima E, Hoshinaga K, Ogawa O, Hasegawa A, et al (2002) ABO-
incompatible living-donor kidney transplantation in children. Transplantation; 74(2):284-285
23. Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J (1983)
Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
Transfusion 23(4):277-285
24. Balint B, Radovic M, Taseski J, Calija B (1986) Investigation of the hydrosoluble type group-
specific ABH and Lewis substances. Acta Antropol Yugoslav 23(1):5-12
25. Terasaki P (1989) Benefical effect of transfusion on kidney transplants. Vox Sang
57:158-160
26. Burlingam WJ, Solinger HW (1986) Action of donor-specific transfusions - analysis of three
possible mechanisms. Transplant Proc 18:685-689
